Immunotherapy Today

Immunotherapy News From Around The World

< Immunotherapy Today home

Author: btwatson

  • Immunotherapy combo halts rare, stage 4 sarcoma in teen – EurekAlert
  • Immunotherapy combo halts rare, stage 4 sarcoma in teen – EurekAlert
  • Immunotherapy Expert Puts Fresh Focus on AEs – OncLive
    Immunotherapy Expert Puts Fresh Focus on AEs – OncLive
  • Immunotherapy for Prostate Cancer: Treatments for the “Lethal” Phenotype – DocWire News
    Immunotherapy for Prostate Cancer: Treatments for the “Lethal” Phenotype – DocWire News
  • Immunotherapy combo halts rare, stage 4 sarcoma in teen – EurekAlert
  • Follicular Lymphoma Treatment Could Rely on Immunotherapy in Therapy Sequencing – Curetoday.com
    Follicular Lymphoma Treatment Could Rely on Immunotherapy in Therapy Sequencing – Curetoday.com
  • A Phase IB/II Study of Lucitanib and Nivolumab Immunotherapy in Women with Advanced Gynecologic Cancers – On Cancer – Memorial Sloan Kettering
  • Immunotherapy combo halts rare, stage 4 sarcoma in teen – EurekAlert
  • Immunotherapy for Prostate Cancer: Treatments for the “Lethal” Phenotype – DocWire News
    Immunotherapy for Prostate Cancer: Treatments for the “Lethal” Phenotype – DocWire News
  • Fate Therapeutics Announces Presentations at the 2020 Society for Immunotherapy of Cancer Annual Meeting – GlobeNewswire
    Fate Therapeutics Announces Presentations at the 2020 Society for Immunotherapy of Cancer Annual Meeting – GlobeNewswire
< Newer Entries   |   Older Entries >
Copyright 2018 ImmunoTherapyToday.com